NOF Corporation Stock

Equities

4403

JP3753400005

Commodity Chemicals

Market Closed - Japan Exchange 02:00:00 2024-04-25 am EDT 5-day change 1st Jan Change
2,069 JPY -0.77% Intraday chart for NOF Corporation -4.08% -11.40%
Sales 2024 * 222B 1.42B Sales 2025 * 237B 1.52B Capitalization 498B 3.2B
Net income 2024 * 31.93B 205M Net income 2025 * 34.07B 219M EV / Sales 2024 * 1.87 x
Net cash position 2024 * 83.6B 537M Net cash position 2025 * 81.6B 524M EV / Sales 2025 * 1.76 x
P/E ratio 2024 *
15.3 x
P/E ratio 2025 *
14.7 x
Employees 3,818
Yield 2024 *
1.87%
Yield 2025 *
1.96%
Free-Float 87.53%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.77%
1 week-4.08%
Current month-0.79%
1 month-5.31%
3 months-8.38%
6 months+4.41%
Current year-11.40%
More quotes
1 week
2 060.00
Extreme 2060
2 160.00
1 month
2 001.00
Extreme 2001
2 183.67
Current year
2 001.00
Extreme 2001
2 454.67
1 year
1 920.00
Extreme 1920
2 454.67
3 years
1 473.33
Extreme 1473.3333
2 454.67
5 years
932.33
Extreme 932.3333
2 454.67
10 years
423.33
Extreme 423.3333
2 454.67
More quotes
Managers TitleAgeSince
President 68 80-03-31
Director/Board Member - -
Director/Board Member 63 85-03-31
Members of the board TitleAgeSince
Director/Board Member - -
Director/Board Member 67 81-03-31
President 68 80-03-31
More insiders
Date Price Change Volume
24-04-25 2,069 -0.77% 278 600
24-04-24 2,085 -0.10% 388,700
24-04-23 2,087 +0.31% 352,300
24-04-22 2,080 +0.39% 534,800
24-04-19 2,072 -3.92% 573,400

Delayed Quote Japan Exchange, April 25, 2024 at 02:00 am EDT

More quotes
NOF CORPORATION is mainly engaged in the functional chemical products business, life science business and others. The Company operates in three segments. The Functional Chemical segment is engaged in the manufacture and sale of fatty acids, fatty acid derivatives, surfactants, ethylene oxide and propylene oxide derivatives, organic peroxides, petroleum chemicals, functional polymers, functional films, electronic materials and special rust prevention agents, as well as the rust prevention processing. The Life Science segment is engaged in the manufacture and sale of drug formulation materials for drug delivery systems (DDSs), edible oils and fats and health food products, among others. The Chemical segment is engaged in the manufacture and sale of industrial explosives, defense-related items, space-related products. The Company also operates in transportation business and real estate business.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2,085 JPY
Average target price
2,833 JPY
Spread / Average Target
+35.90%
Consensus